Calyxt Inc (NASDAQ:CLXT) insider Daniel F. Voytas sold 4,666 shares of the stock in a transaction on Monday, August 20th. The shares were sold at an average price of $17.31, for a total value of $80,768.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Daniel F. Voytas also recently made the following trade(s):

  • On Wednesday, August 8th, Daniel F. Voytas sold 4,083 shares of Calyxt stock. The shares were sold at an average price of $17.48, for a total value of $71,370.84.
  • On Monday, July 9th, Daniel F. Voytas sold 4,083 shares of Calyxt stock. The shares were sold at an average price of $17.84, for a total value of $72,840.72.
  • On Wednesday, June 20th, Daniel F. Voytas sold 4,666 shares of Calyxt stock. The shares were sold at an average price of $20.56, for a total value of $95,932.96.
  • On Friday, June 15th, Daniel F. Voytas sold 7,539 shares of Calyxt stock. The shares were sold at an average price of $19.49, for a total value of $146,935.11.

CLXT remained flat at $$17.32 during trading on Friday. 45,626 shares of the company’s stock were exchanged, compared to its average volume of 63,878. The company has a quick ratio of 21.27, a current ratio of 21.27 and a debt-to-equity ratio of 0.16. The company has a market capitalization of $554.74 million and a PE ratio of -15.46. Calyxt Inc has a twelve month low of $13.09 and a twelve month high of $31.89.

Calyxt (NASDAQ:CLXT) last issued its quarterly earnings results on Wednesday, August 1st. The company reported ($0.25) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.22) by ($0.03). The firm had revenue of $0.20 million for the quarter, compared to the consensus estimate of $0.10 million. Calyxt had a negative net margin of 7,253.78% and a negative return on equity of 45.34%. research analysts forecast that Calyxt Inc will post -1.02 EPS for the current fiscal year.

A number of research firms recently weighed in on CLXT. Jefferies Financial Group restated a “buy” rating and issued a $27.00 price objective on shares of Calyxt in a report on Friday, June 22nd. ValuEngine raised shares of Calyxt from a “hold” rating to a “buy” rating in a research report on Friday, July 20th. Finally, Zacks Investment Research raised shares of Calyxt from a “hold” rating to a “buy” rating and set a $19.00 price target on the stock in a research report on Monday, May 28th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. Calyxt currently has an average rating of “Buy” and a consensus target price of $27.38.

Institutional investors and hedge funds have recently modified their holdings of the business. Wells Fargo & Company MN boosted its position in shares of Calyxt by 1,421.9% during the 4th quarter. Wells Fargo & Company MN now owns 30,788 shares of the company’s stock worth $678,000 after purchasing an additional 28,765 shares in the last quarter. Deutsche Bank AG boosted its position in shares of Calyxt by 151.3% during the 4th quarter. Deutsche Bank AG now owns 18,378 shares of the company’s stock worth $404,000 after purchasing an additional 11,064 shares in the last quarter. Goldman Sachs Group Inc. bought a new position in shares of Calyxt during the 4th quarter worth about $330,000. Perkins Capital Management Inc. bought a new position in shares of Calyxt during the 2nd quarter worth about $833,000. Finally, Granite Investment Partners LLC bought a new position in shares of Calyxt during the 2nd quarter worth about $216,000. 24.86% of the stock is currently owned by institutional investors and hedge funds.

Calyxt Company Profile

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.

Further Reading: Average Daily Trade Volume – What It Means In Stock Trading

Insider Buying and Selling by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.